Related Experiment Video
Updated: Feb 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Role of complement system in patients with biopsy-proven immunoglobulin G4-related kidney disease
Rong Wang1, Dafeng He1, Lili Zhao2
1National Clinical Research Center of Kidney Diseases, Jinling Clinical Medical College of Nanjing Medical University, Nanjing 210002, Jiangsu, China; Nephrology Department, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, Jiangsu, China.
Insights
Immunoglobulin G4-related kidney disease (IgG4-RKD) is rare, but complement system activation may play a role in its development. Lower C3 levels correlate with more severe IgG4-RKD indicators.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Hypocomplementemia is frequently observed in immunoglobulin G4-related kidney disease (IgG4-RKD).
- The specific role of the complement system in IgG4-RKD pathogenesis remains understudied.
- IgG4-RKD is a rare renal disease characterized by IgG4-positive plasma cell infiltration.
Purpose of the Study:
- To investigate the association between complement system activation, particularly C3 levels, and the clinical and pathological features of IgG4-RKD.
- To explore the potential role of complement in the development and progression of IgG4-RKD.
Main Methods:
- Retrospective analysis of 17 patients diagnosed with IgG4-RKD based on renal biopsy findings (January 2010-January 2018).
- Patients were categorized into low-C3 (<0.8 μg/L) and normal-C3 (≥0.8 μg/L) groups.
- Comparison of clinical parameters, serological markers, and renal histopathology between the two groups.
Main Results:
- The low-C3 group exhibited lower C4 levels, higher IgG4 levels, increased rheumatoid factor positivity, and more severe storiform fibrosis compared to the normal-C3 group.
- Serum C3 levels showed a negative correlation with serum IgG4, rheumatoid factor, renal C1q deposition, storiform fibrosis, interstitial fibrosis scores, and renal IgG4+ plasma cells.
- Lower C3 levels were also associated with higher blood urea nitrogen levels at the latest follow-up.
Conclusions:
- IgG4-RKD is a rare renal entity.
- The complement system, particularly C3, appears to be involved in the pathogenesis of IgG4-RKD.
- Complement activation may correlate with disease severity and specific histopathological findings in IgG4-RKD.
Abstract:
Hypocomplementemia has been frequently reported in immunoglobulin G4-related kidney disease (IgG4-RKD). However, studies on the role of complement system in IgG4-RKD are lacking. A total of 40 429 renal biopsies from January 2010 to January 2018 were reexamined in the present study, and 17 patients were confirmed to meet the criteria of IgG4-RKD. According to the serum C3 levels, they were divided into 2 groups: the low-C3 group (C3 <0.8 g/L, n = 7) and the normal-C3 group (C3 ≥0.8 g/L, n = 10). Compared with the normal-C3-level group, the patients in the low-C3-level group had lower serum C4 concentrations (P = .025), higher serum IgG4 concentrations (P = .003), higher positive rates in rheumatoid factor (P = .033), more severe storiform fibrosis (P = .007) at diagnosis, and higher blood urea nitrogen levels at the latest test (P = .04). The serum levels of C3 were in negative correlation with the serum levels of IgG4 (P = .003), the levels of rheumatoid factor (P = .002), renal deposition of C1q (P = .028), storiform fibrosis (P < .001), scores of interstitial fibrosis (P = .015), the amount of renal IgG4-positive (IgG4+) plasma cells (P = .020), the ratios of IgG4+ plasma cells/CD138+ cells (P = .018), and the blood urea nitrogen concentrations at the last test (P = .023). Our study shows that IgG4-RKD is a relatively rare entity. Complement system may participate in the development of IgG4-RKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Complement System
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

